Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients

The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD

NCT01243788 ·Status: UNKNOWN ·Phase: PHASE4

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

NCT01721291 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00856193 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01475292 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation

NCT04509661 ·Status: UNKNOWN ·Phase: PHASE4

A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

NCT06980142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Effects of COPD Standardized Management on COPD Exacerbation

NCT04664491 ·Status: RECRUITING ·Phase: NA

Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis

NCT02782312 ·Status: COMPLETED ·Phase: PHASE4

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease

NCT00180843 ·Status: TERMINATED ·Phase: NA

The Asthma Bronchial Challenge Study

NCT03575663 ·Status: COMPLETED

The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD

NCT04675463 ·Status: UNKNOWN ·Phase: NA

The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis

NCT01769898 ·Status: COMPLETED ·Phase: PHASE4

Muco-ciliary Cleansing of Lungs in COPD With and Without a Salt Particle Inhaler

NCT03927365 ·Status: SUSPENDED ·Phase: NA

A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)

NCT00482235 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

NCT00280371 ·Status: COMPLETED ·Phase: PHASE3

A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)

NCT00418613 ·Status: COMPLETED ·Phase: PHASE2

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

NCT01712516 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

NCT05987371 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT07292714 ·Status: RECRUITING ·Phase: PHASE2

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01204034 ·Status: COMPLETED ·Phase: PHASE3

Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease

NCT02455362 ·Status: WITHDRAWN ·Phase: PHASE3

Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

NCT07147946 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02182674 ·Status: COMPLETED ·Phase: PHASE2

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

NCT00117182 ·Status: COMPLETED ·Phase: PHASE2

IPF Drug Deposition Study

NCT01457261 ·Status: COMPLETED ·Phase: PHASE1